Background: Integrated PET/MRI with hyperpolarized 13 C magnetic resonance spectroscopic imaging ( 13 C-MRSI) offers simultaneous, dual-modality metabolic imaging. A prerequisite for the use of simultaneous imaging is the absence of interference between the two modalities. This has been documented for a clinical whole-body system using simultaneous
Background
Integrated PET/MRI offers the combination of functional imaging of positron emission tomography (PET) and high soft-tissue contrast of anatomic magnetic resonance imaging (MRI) in a simultaneous acquisition. Clinical MRI is for the major part based on 1 H nuclei, which are predominantly present in water. 1 H-MRI has also functional capabilities, for instance to measure perfusion, characterize tissue cellularity through diffusion-weighted MRI, and study metabolites with magnetic resonance spectroscopy (MRS). The use of MRS imaging (MRSI) is, however, in general challenged by the low sensitivity of in vivo MRI. Hyperpolarized MRI offers a signal increase by many orders of magnitude. Recently, the feasibility of using a 13 C-labeled pyruvate substrate, hyperpolarized through the dynamic nuclear polarization method [1] , for imaging of tumor metabolism in man was demonstrated [2] . Hence metabolic imaging based on 13 C-MRSI has come within the reach of routine clinical use.
PET is an established clinical method for metabolic imaging. For example, in oncology, the tracer 18 F-2-fluoro-2-deoxy-D-glucose (FDG) gives a measure of glucose metabolism. Since both 13 C-MRSI and FDG-PET are metabolic imaging techniques, comparison studies are highly relevant [3] and have been pursued using sequential 13 C-MRSI and PET [4, 5] . In the setting of integrated PET/MRI, simultaneous hyperpolarized 13 C-MRSI and PET could become a reality. Such a setup could be very important for generation of new knowledge in physiology and pathophysiology as well as demonstrating potential clinical benefits of 13 C-MRSI.
A prerequisite for the use of simultaneous PET and MRI is the absence of interference between the two systems for reviews; see, e.g., [6] [7] [8] . Absence of interference has been documented for a clinical whole-body system using simultaneous 1 H-MRI and PET [9] but never for 13 C-MRS(I) and PET. Radio frequency (RF) electromagnetic radiation, which is both transmitted and picked up by MRI coils, is a wellknown potential source of interference both from MRI to PET and vice versa [7] . PET systems based on solid-state photodetectors have a major part of the electronics placed in close proximity to the MRI RF system. To avoid cross-talk, PET electronics is shielded by a conducting material [10] [11] [12] [13] [14] [15] [16] . The shielding material can induce eddy currents and magnetic field inhomogeneities, and the thickness of the material must therefore be minimized [11] ; e.g., for a human brain PET insert, a 10-μm copper shield was used [15] . The magnetic resonance frequency is approximately four times lower for 13 C than that for 1 H due to the lower gyromagnetic ratio. Shielding efficiency depends on the square root of the frequency of the electromagnetic radiation and can be characterized by a penetration depth. Therefore, shielding optimized for 1 H-MRI may not be similarly efficient for 13 C-MRSI. Apart from shielding effects, also the magnetic field gradients employed for spatial encoding can potentially introduce noise in the PET measurement system [7] . Due to the lower gyromagnetic ratio, the amplitude of the imaging gradients may be increased. The lower 13 C resonance frequency and as well the corresponding need for higher imaging gradients imply that performance measurements for simultaneous 1 H-MR(S)I and PET cannot be directly translated to simultaneous 13 C-MRSI and PET. Thus, the aim of the present work is to demonstrate the feasibility of simultaneous PET and 13 C-MRSI in an integrated whole-body PET/MRI hybrid scanner. Phantom experiments were carried out to investigate if simultaneous 13 C-MRSI and PET acquisition is possible without influencing the PET and 13 C-MRSI quantification.
Furthermore, we aimed to demonstrate that the system is capable of hyperpolarized 13 C-MRSI.
Methods

Experimental setup
Combined PET and MRI were performed using an integrated PET/MRI system (Siemens Biograph mMR, Erlangen, Germany). The phantom setups employed are shown in Figs. 1 and 2 . An overview of all measurements is shown in Table 1 . The PET performance (Fig. 1 ) was evaluated using a body-mimicking phantom (PTW, Freiburg, Germany) which is part of image quality tests according to the standard of the National Electrical Manufacturers Association (NEMA). The background part of the NEMA phantom was filled with demineralized water with added NaCl (5 g/L) and NiSO 4 (3.75 g/L) for improving MR image quality compared to pure water [8] . A set of hollow spheres was filled with an aqueous solution of [ For later alignment with CT data, a total of six fish oil capsules were placed at various positions at the phantom. 
Hyperpolarization experiment
At the end of the PET/MRI NEMA phantom scan session, a hyperpolarization experiment was carried out. Hyperpolarized 13 C-pyruvate was produced using the SpinLab system (GE Healthcare, Milwaukee, WI, USA). The sample consisted of [1-13 C]pyruvic acid mixed with an electron paramagnetic agent (sample concentration 15 mM) manufactured by Syncom (Groningen, Netherlands, PN AH111501) under contract from General Electric. The dissolution media applied contained 0.1 g/L ethylenediaminetetraacetic acid disodium salt dehydrate (EDTA disodium salt, Sigma PN E4994) in water, and the neutralization media used to neutralize the hyperpolarized [1-13 C]pyruvic acid sample prior to injection contained 0.72 M NaOH, 0.4 M Tris, and 0.1 g/L EDTA disodium salt in water. A 60-mL syringe with hyperpolarized 13 C-pyruvate was placed in the abovementioned holder. Imaging took place immediately hereafter using the above CSI sequence with the flip angle reduced to 1°.
CT data acquisition
Following the PET/MR NEMA phantom scan session, a CT (Siemens Biograph mCT) scan of the NEMA phantom including the coil was performed. The phantom was centered as in the PET/MR. The low-dose CT (120 kVp, 3-mm slices) scan was used for CT-based attenuation correction (CTAC).
PET reconstruction
PET images of the NEMA phantom from both the PET and MR were reconstructed using vendor-supplied 3D OP-OSEM with 4 iterations, 21 subsets, and a 4-mm Gaussian filter. Voxel size was 2.08 × 2.08 × 2.03 mm 3 with matrix 344.
For PET/MR CTAC, the low-dose CT image was used. First, the PET/CT patient table was manually removed using OsiriX (v. 4.1.2, Pixmeo, Geneva, Switzerland). CT images were subsequently aligned with the MR VIBE images using Minc (minctracc, McConnell Imaging Center, Montreal), whereupon the Hounsfield units were converted to linear attenuation coefficients using the bi-linear scaling of Carney et al. [17] as implemented in our PET/CT systems. The patient bed of the PET/MR is automatically included in the AC map by the vendor-supplied algorithm. No additional hardware elements were present during the PET/MR scan session. The first minute of the PET acquisition (during which simultaneous Dixon MRI was performed) was excluded from all reconstructions to study the possible effect of 13 C-MRSI only.
PET/MR data acquisition, mMR water phantom
The mMR phantom setup (Fig. 2) was placed on the patient table with the 13 C loop coil in the isocenter of the scanner. A calibration of the 13 C MR flip angle was performed using the urea vial with the same procedure as above.
To evaluate the effect of the PET data acquisition system on the 13 C-MRSI, 13 C-MRSI was performed with the PET gantry in an "ON" or "OFF" state. With the PET gantry in the OFF state, all PET electronics inside the Faraday cage of the PET/MRI examination room are switched off. This procedure can be accessed through the service module of the system. A total of 24 13 C-MRSI acquisitions were performed. During acquisitions with scan numbers 17-20 and 25-28, the PET gantry was ON; during acquisitions with scan numbers 21-24, the PET gantry was OFF. The ON-OFF-ON design was chosen as a slight temporal drift of the 13 C-MRSI urea peak height was noted during preparation of the measurements. The ON-OFF-ON set of measurements was repeated 14 h later when the activity of the phantom had decayed to less than 1 % of its initial value. Please refer to Table 1 for an overview of measurements. For 13 C-MRSI, the above CSI sequence was used again (one repetition only). A 1 H-MRI VIBE sequence with parameters as above was obtained as a structural reference.
Evaluation of PET quantification
We report the average PET activity value (kBq/mL) of a spherical VOI with a diameter of 20 mm, centrally placed in the largest sphere (with an inside diameter of 37 mm). Background activity was measured using a spherical VOI with a diameter of 60 mm, placed in the center of the phantom. PET activity was decay corrected to the time of the filling of the phantom. In addition, the total number of trues for each PET acquisition on the PET/MR system was obtained from the list mode files (total prompts subtracted total randoms) and corrected for decay and the differences in acquisition times. Percent differences between PET acquisitions obtained with 13 C-MRSI active (ON) or not (OFF) were calculated using the 13 C-MRSI OFF condition as the reference. Differences were evaluated using a two-sample t test. The noise was estimated as the standard deviation of the real part of the signal, multiplied by the square root of the number of repetitions of the MRSI. 13 C-MRSI signal-to-noise ratio (SNR) was estimated for urea and acetate using the voxel with maximum signal. The signal was defined as the integrated peak area [18] in an interval of ±250 Hz around the peak. Percent differences of SNR between 13 C-MRSI acquisitions for the mMR water phantom obtained with PET gantry "ON" or "OFF" were calculated using the OFF condition as the reference. Differences were evaluated using a two-sample t test. Differences were evaluated both with and without high activity in the gantry (see Table 1 ).
Statistical evaluation
Data are reported with 95 % confidence intervals (CI), and a p value of 0.05 was considered significant.
Results
On a general note, PET and 13 C-MRSI data acquisition could be performed simultaneously without any practical issues.
PET quality
As an example of PET quality, reconstructed transverse images from scan numbers 1 ( 13 C-MRSI "ON") and 2 ( 13 C-MRSI "OFF") are shown in Fig. 3 . Line plots of average activity during 13 C-MRSI ON and OFF conditions are shown in Fig. 4 . No artifacts from the simultaneous 13 C-MRSI acquisition were discerned. However, both background profiles show a peak towards the center. Figure 5 shows PET activity in the largest sphere and the background for all 16 PET acquisitions. There was no visible time dependence or dependence on whether the 13 C-MRSI was ON or OFF.
The results are summarized in Table 2 . The average difference in PET activity between acquisitions with 13 C-MRSI ON and OFF was 0.83 (largest sphere) and −0.76 % (background). The differences were not significant (p = 0.18, CI (−0.42 to 2.07 %) and p = 0.16, CI (−1.85 to 0.33 %)) for the largest sphere and background, respectively. The average difference in net trues was −0.01 % and was not significant (p = 0.97, CI (−0.38 to 0.37 %)). There was no apparent dependence on whether the PET gantry was OFF or ON, neither in the condition with PET activity high (Fig. 6a) nor low (Fig. 6b) . However, a tendency to an overall temporal drift can be noticed in Fig. 6b . The average difference in SNR between acquisitions with high PET activity and PET gantry ON versus OFF was 1.21 % and was not significant (p = 0.31, CI (−1.27 to 3.67 %)) for 
Discussion
The presented phantom data demonstrates that simultaneous PET and 13 C-MRSI in a whole-body PET/MRI scanner is possible. Interference effects introduced by acquiring data from the two modalities simultaneously are small and non-significant. Hence, full advantage can be taken of the integrated PET/MRI scanner design. Furthermore, the integrated PET/MRI system was proven capable of hyperpolarized 13 C-MRSI.
A simultaneous acquisition of PET and 13 C-MRSI will reduce total examination time and minimize subject motion between the imaging modalities, which is likely to be beneficial for in vivo studies. Also, functional imaging can be performed without a delay between the modalities, thus ensuring that the physiologic state of the subject is unchanged. This is particularly desirable when 13 C-MRSI is combined with PET tracers C spectra under conditions of the PET gantry ON and OFF, as denoted in the legend. Spectra are from the voxel with the maximum urea signal and zoomed on the urea peak to highlight the small differences of the spectra using a short uptake time and in cases where a pharmacological challenge or another intervention is employed.
The PET results presented here using a standard quality assurance phantom shows no effect of simultaneous 13 C-MRSI (Figs. 3 and 4) . The statistical analysis of our repeated measurements (Fig. 5 ) allows us to conclude that the maximum possible quantitative PET estimation error due to interference from the 13 C-MRSI is below 2 % (95 % CI). That can be considered a sufficiently low error for clinical and research purposes. The CSI sequence used to test interference with PET is a typical type of sequence for hyperpolarized MRSI. The RF flip angle was set to 29°, corresponding to the Ernst angle for a typical tissue longitudinal MR relaxation time (T 1 ) of 1000 ms, giving a maximum signal for a thermal polarization. In case of hyperpolarized MRI, most often a lower flip angle is chosen (e.g., 10°in Ref. [2] ) to preserve the hyperpolarization as long as possible. Hence in practice, possible interference effects caused by RF radiation will be smaller than in the present experiment.
When MRI is not performed, no RF radiation is transmitted and the magnetic field is constant. Conversely, there is no fundamental change of state of the PET detector system between situations where imaging data is collected or not. A possible RF interference from the PET detector system to the 13 C-MRSI would depend on the PET gantry being powered on or off. However, no effect of power state is observed (Figs. 6,  7 , and 8). The maximum 13 C-MRSI SNR error due to PET gantry power state is below −6 to +4 % (95 % CI) for all measurements. A tendency to temporal drift in the Fig. 9 Examples of 13 C-MRSI. 13 C-MRSI metabolite images (color, scale bar inserted) overlaid on 1 H-MRI (lower left). upper row: Acetate and urea metabolite images. lower right: Image of hyperpolarized pyruvate measurements, seemingly unrelated to the power state (see Fig. 6b ), could have inflated the error estimation. The ON-OFF-ON design of the experiment will compensate for a linear trend of system instability only. Overall though, a stability of a few percent on 13 C-MRSI SNR in a single 19-s acquisition as used here can be considered satisfactory.
The present study was not designed to investigate a hypothetical overall (i.e., PET acquisition and activity independent) degradation of the 13 C-MRSI due to the PET system. For example, the presence of the PET detector system could degrade the static magnetic field inhomogeneity; however, this was shown not to be the case for the PET/ MRI system used here by Delso et al. [9] . The focus of the present work was on RF effects which depend on the gyromagnetic ratio and hence potentially differ from 1 H-to 13 C-based imaging.
Importantly, the 13 C-MRSI quality in this integrated PET/MRI setup was sufficient to perform metabolic imaging using hyperpolarization in a phantom setting (Fig. 9 ) and also recently for in vivo experiments [19, 20] .
We noticed an unexpected non-uniform activity in the background region of the NEMA phantom (Fig. 4b) . The non-uniformity could originate from suboptimal attenuation or scatter correction of the setup and deserves further investigation. However, the profile appeared to be independent of the 13 C-MRSI acquisition. Further challenges specific to simultaneous PET and 13 C-MRSI include characterization and correction for photon attenuation due to 13 C coils. Preliminary investigations at our institution indicate that this effect can change PET activity values with up to 10 %, however, without any change in visual interpretation of images.
Conclusions
The present work demonstrated the feasibility of simultaneous PET and 13 C-MRSI in an integrated whole-body PET/MRI hybrid scanner. Phantom experiments showed that simultaneous 13 C-MRSI and FDG-PET acquisition is possible without influencing the PET quantification. Furthermore, the system is capable of hyperpolarized 13 C-MRSI.
Hereby, the way is paved for simultaneous PET and hyperpolarized 13 C-MRI in vivo studies.
